Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients

Anesthesiology

Volumn 84, Issue 2, 1996, Pages 330-339

  Alloul, Karine ^a   Whalley, David G ^b   Shutway, Fanny ^b   Ebrahim, Zeyd ^b   Varin, France ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Anticonvulsants: carbamazepine; Neuromuscular relaxants: vecuronium; Pharmacodynamics: carbamazepine; vecuronium; Pharmacokinetics: carbamazepine; vecuronium

Indexed keywords

CARBAMAZEPINE; DEXAMETHASONE; DROPERIDOL; FUROSEMIDE; GLYCERYL TRINITRATE; HYDRALAZINE; LABETALOL; MANNITOL; OXACILLIN; RANITIDINE; SUFENTANIL; THIOPENTAL; VECURONIUM;

ADULT; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG SCREENING; EPILEPSY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PRIORITY JOURNAL;

ADULT; ANESTHESIA RECOVERY PERIOD; ANTICONVULSANTS; CARBAMAZEPINE; DRUG RESISTANCE; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR NONDEPOLARIZING AGENTS; VECURONIUM BROMIDE;

EID: 0030041706     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199602000-00010     Document Type: Article

References (32)

1. Roth S, Ebrahim ZY: Resistance to pancuronium in patients receiving carbamazepine ANESTHESIOLOGY 1987; 66:691-3
2. Ornstein E, Matteo RS, Weinstein JA, Halevy JD, Young WL, Abou-Donia MM: Accelerated recovery from doxacurium-induced neuromuscular blockade in patients receiving chronic anticonvulsant therapy. J Clin Anesth 1991; 3:108-11
3. Whalley DG, Ebrahim ZY: Influence of carbamazepine on the dose-response relationship of vecuronium. Br J Anaesth 1994; 72: 125-6
4. Ornstein E, Matteo RS, Schwartz AE, Silverberg PA, Young WL, Diaz J: The effect of phenytoin on the magnitude and duration of neuromuscular block following atracurium or vecuronium ANESTHESIOLOGY 1987; 67:191-6
5. Tempelhoff R, Modica PA, Jellish WS, Spitznagel EL: Resistance to atracurium - induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg 1990; 71:665-9
6. Hickey DR, Sangwan S, Bevan JC: Phenytoin-induced resistance to pancuronium. Use of atracurium infusion in management of a neurosurgical patient. Anaesthesia 1988; 43:757-9
7. Jellish WS, Modica PA, Tempelhoff R: Accelerated recovery from pipecuronium in patients treated with chronic anticonvulsant therapy. J Clin Anesth 1993; 5:105-8
8. Kim CS, Arnold FJ, Itani MS, Martyn JA: Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. ANESTHESIOLOGY 1992; 77:500-6
9. Ornstein E, Matteo RS, Young WL, Diaz J: Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin. ANESTHESIOLOGY 1985; 63:294-8
10. SzenohradszkyJ, Caldwell JE, Sharma ML, Gruenke LD, Miller RD: Interaction of rocuronium (ORG 9426) and phenytoin in a patient undergoing cadaver renal transplantation: A possible pharmacokinetic mechanism? ANESTHESIOLOGY 1994; 80:1167-70
11. Platt PR, Thackray NM: Phenytoin-induced resistance to vecuronium. Anaesth Intensive Care 1993; 21:185-91
12. Ducharme J, Varin F, Bevan DR, Donati F, Théorêt Y: High-performance liquid chromatography-electrochemical detection of vecuronium and its metabolites in human plasma. J Chromatogr 1992; 573:79-86
13. Gibaldi M, Perrier D. Drugs and the pharmaceutical sciences. Pharmacokinetics. Volume 15 2nd edition. New York, Marcel Dekker, 1982, pp 445-9
14. Yamaoka K, Nakagawa T, Uno T: Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978; 6:165-75
15. Fuseau E, Sheiner LB: Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric pharmacodynamic model. Clinical Pharmacol Ther 1984; 35:733-41
16. Holford NH, Sheiner LB: Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 1981; 6:429-53
17. Gray HS, Slater RM, Pollard BJ: The effect of acutely administered phenytoin on vecuronium-induced neuromuscular blockade. Anaesthesia 1989; 44:379-81
18. Ducharme J, Varin F, Bevan DR, Donati F: Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters. Clin Pharmacokinet 1993; 24:507-18
19. Lebrault C, Duvaldestin P, Henzel D, Chauvin M, Guesnon P: Pharmacokinetics and pharmacodynamics of vecuronium in patients with cholestasis. Br J Anaesth 1986; 58:983-7
20. Lynam DP, Cronnelly R, Castagnoli KP, Canfell PC, Caldwell J, Arden J, Miller RD: The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure. ANESTHESIOLOGY 1988; 69:227-31
21. Bencini AF, Mol WE, Scaf AH, Kersten UW, Wolters KT, Agoston S, Meijer DK: Uptake and excretion of vecuronium bromide and pancuronium bromide in the isolated perfused rat liver. ANESTHESIOLOGY 1988; 69:487-92
22. Mol WE, Fokkema GN, Ween B, Meijer DK: Mechanisms for the hepatic uptake of organic cations. Studies with the muscle relaxant vecuronium in isolated rat hepatocytes. J Pharmacol Exp Ther 1988; 244:268-75
23. Bencini AF, Scaf AHJ, Sohn YJ, Kernsten-Kleef UW, Agoston S: Hepatobiliary disposition of vecuronium bromide in man. Br J Anaesth 1986; 58:988-95
24. Upton RA, Nguyen TL, Miller RD, Castagnoli NJR: Renal and biliary elimination of vecuronium (ORG NC 45) and pancuronium in rats. Anesth Analg 1982; 61:313-6
25. Bencini AF, Scaf AH, Agoston S, Houwertjes MC, Kersten UW: Disposition of vecuronium bromide in the cat. Br J Anaesth 1985; 57:782-8
26. Pirttiaho HI, Sotaniemi EA, Pelkonen RO, Pitkanen U: Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol 1982; 22:441-5
27. Pirttiaho HI, Sotaniemi EA, Ahokas JT, Pitkanen U: Liver size and indices of drug metabolism in epileptics. Br J Clin Pharmacol 1978; 6.273-8
28. Brotherton WP, Matteo RS: Pharmacokinetics and pharmacodynamics of metocurine in humans with and without renal failure. ANESTHESIOLOGY 1981; 55:273-6
29. Agoston S, Vandenhrom RHG, Wierda JKH: Clinical pharmacokinetics of neuromuscular blocking drugs. Clin Pharmacokinet 1992; 22:94-115
30. Bencini AF, Houwertjes MC, Agoston S: Effects of hepatic uptake of vecuronium bromide and its putative metabolites on their neuromuscular blocking actions in the cat. Br J Anaesth 1985; 57: 789-95
31. Ducharme J, Donati F: Pharmacokinetics and pharmacodynamics of steroidal muscle relaxants. Anesth Clin North Am 1993; 11:283-307
32. Levy RH, Koch KM: Drug interactions with valproic acid. Drugs 1982; 24:543-56